D&D Pharmatech Inc. (KOSDAQ:347850)

D&D Pharmatech Revenue

D&D Pharmatech had revenue of 662.06M KRW in the quarter ending June 30, 2026, a decrease of -28.39%. This brings the company's total for the last twelve months to 2.75B, down -70.53% year-over-year. In the year 2025, D&D Pharmatech had annual revenue of 4.30B, down -62.42%. That makes D&D Pharmatech the 42,352nd largest company in the world by revenue and 2,566th in South Korea.

• Revenue (ttm): 2.75B
• Revenue Growth: -70.53%
• P/S Ratio: 686.62
• Revenue / Employee: 110.02M
• Employees: 25
• Market Cap: 1.89T

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• USA 3.78B 88.0%
• China 515.11M 12.0%

Fiscal year ended Dec 31, 2025 See the full D&D Pharmatech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.30B	-7.14B	-62.42%
Dec 31, 2024	11.44B	-7.24B	-38.77%
Dec 31, 2023	18.68B	18.07B	2,958.97%
Dec 31, 2022	610.57M	-753.54M	-55.24%
Dec 31, 2021	1.36B	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error